| 000 | 01620 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518045151.0 | ||
| 264 | 0 | _c20200129 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1756-185X | ||
| 024 | 7 |
_a10.1111/1756-185X.13611 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTang, Chao-Hsiun | |
| 245 | 0 | 0 |
_aPotential benefits of biologics on stroke and mortality in patients with rheumatoid arthritis: A nationwide population-based cohort study in Taiwan. _h[electronic resource] |
| 260 |
_bInternational journal of rheumatic diseases _cAug 2019 |
||
| 300 |
_a1544-1552 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdiagnosis |
| 650 | 0 | 4 |
_aBiological Products _xadverse effects |
| 650 | 0 | 4 | _aCause of Death |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProtective Factors |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aStroke _xdiagnosis |
| 650 | 0 | 4 |
_aTaiwan _xepidemiology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aYu, Fun | |
| 700 | 1 | _aHuang, Ching-Ya | |
| 700 | 1 | _aChen, Der-Yuan | |
| 773 | 0 |
_tInternational journal of rheumatic diseases _gvol. 22 _gno. 8 _gp. 1544-1552 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/1756-185X.13611 _zAvailable from publisher's website |
| 999 |
_c29837555 _d29837555 |
||